foxo4-dri human trial senolytic

foxo4-dri human trial senolytic The costs and benefits of senotherapeutics for health FOXO4-DRI induces keloid senescent fibroblast

Name: foxo4-dri human trial senolytic The costs and benefits of senotherapeutics for health FOXO4-DRI induces keloid senescent fibroblast
Brand: equiscorp.hu
SKU: 22559486740
Price: 27.65 USD
Availability: InStock
Rating: 4.7776000000000005 (6 reviews)

FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine FOXO4 DRI Vial 10mg Stemcode Peptides The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications

SKU: 22559486740 · From equiscorp.hu

4.8

USD27.65 USD47.65

Pay in 4 interest-free payments of $6.91 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

Crafted for easy breathing, it provides a soft, odorless, and non-irritating experience

R 3 is H, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, optionally substituted C 3 -C 6 cycloalkyl, optionally substituted C 2 -C 7 heterocycloalkyl, optionally substituted C 6 -C 10 aryl, optionally substituted C 3 -C 9 heteroaryl, OR 6 , NR 5 R 6 , C(O)R 7 , -0O 2 R 6 , C(O)NR 5 R 6 , N(R 5 )C(O)R 7 , N(R 5 )CO 2 R 7 , NHS(O) 2 R 7 , S(O) 2 NR 5 R 6 , or R 2 and R 3 together form an optionally substituted C 2 -C 7 heterocycloalkyl ring